This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Progenika Biopharma S.a.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovations of Pedro Mata Lopez in Genetic Analysis
Introduction
Pedro Mata Lopez is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of genetic analysis, particularly in the detection of mutations associated with familial hypercholesterolemia. His innovative work has implications for understanding and diagnosing genetic disorders.
Latest Patents
Pedro Mata Lopez holds a patent for a method and device designed for the detection of mutations in isolated gene sequences of the low-density lipoprotein receptor (LDL-r). This invention relates to extracorporeal methods of analyzing the presence or absence of mutations that cause familial hypercholesterolemia. The inventive methods describe how these mutations can be detected using a DNA sample from an individual. The process includes a polymerase chain reaction with primers complementary to the LDL-r gene, followed by analysis of the amplified product through sequencing, restriction analysis, single strand conformation polymorphism techniques, heteroduplex analysis, and the use of a device on a biochip glass support with oligonucleotide probes to detect the mutations in the DNA.
Career Highlights
Pedro Mata Lopez is currently associated with Progenika Biopharma S.A., where he continues to advance his research in genetic analysis. His work has been instrumental in developing methods that enhance the understanding of genetic mutations and their implications for health.
Collaborations
Pedro has collaborated with notable colleagues, including Rodrigo Alberto Alonso Karlezi and Pilar Mozas Alonso. These collaborations have fostered a productive environment for innovation and research in the field of genetics.
Conclusion
Pedro Mata Lopez's contributions to genetic analysis through his innovative patent demonstrate the importance of research in understanding genetic disorders. His work not only advances scientific knowledge but also has the potential to improve diagnostic methods for familial hypercholesterolemia.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile